Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo
K
K
Sakai
S
S
Miyahara
T
T
D001781:Blood Component Removal; D001798:Blood Proteins / Q000032:analysis; D004351:Drug Resistance; D005374:Filtration; D005921:Glomerulonephritis / Q000150:complications*; D005923:Glomerulosclerosis, Focal Segmental / Q000097:blood / Q000150:complications*; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood*; D009404:Nephrotic Syndrome / Q000097:blood / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D010956:Plasmapheresis / Q000379:methods
D001798:Blood Proteins; D008055:Lipids; D008077:Lipoproteins, LDL